# Xanthotoxin

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/xanthotoxin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** 8-methoxypsoralen, 8-MOP, Methoxsalen, Ammoidin, Xanthotoxol methyl ether, Furocoumarin xanthotoxin, Psoralen derivative

## Overview

Xanthotoxin (methoxsalen) is a naturally occurring furocoumarin found in plants such as Ammi majus and Angelica species that exerts its primary effects by intercalating into DNA upon UV activation and modulating inflammatory signaling cascades including NF-κB and MAPK pathways. Preclinical research suggests roles in bone preservation, seizure suppression, and [anti-inflammatory](/ingredients/condition/inflammation) activity, though human clinical data remain limited.

## Health Benefits

• May support [bone health](/ingredients/condition/bone-health) by inhibiting RANKL-induced bone loss (preliminary evidence from animal studies)
• Shows potential anticonvulsant properties against seizures (preclinical animal models only)
• Demonstrates [anti-inflammatory](/ingredients/condition/inflammation) effects through NF-κB and MAPK pathway regulation (in vitro evidence)
• Exhibits anticancer activity by inducing apoptosis via ROS production (laboratory studies)
• Used clinically in PUVA therapy for psoriasis, eczema, and vitiligo (specific trial data not available)

## Mechanism of Action

Xanthotoxin inhibits NF-κB and MAPK (ERK1/2, p38, JNK) signaling pathways, suppressing [pro-inflammatory cytokine](/ingredients/condition/inflammation) production including TNF-α, IL-1β, and IL-6. In bone tissue, it blocks RANKL-induced osteoclastogenesis by downregulating NFATc1 and c-Fos transcription factors, thereby reducing osteoclast differentiation. Upon UVA irradiation, xanthotoxin forms covalent monoadducts and cross-links with pyrimidine bases in DNA, which underlies its established photochemotherapy (PUVA) mechanism for dermatological conditions.

## Clinical Summary

The most robust human evidence for xanthotoxin comes from its pharmaceutical form, methoxsalen, used in PUVA therapy for psoriasis and vitiligo, where controlled trials involving hundreds of patients confirm efficacy in repigmentation and plaque clearance. Anticonvulsant effects have been demonstrated exclusively in rodent models (pentylenetetrazole and maximal electroshock seizure tests) with no controlled human trials conducted to date. Bone-protective findings derive from in vitro osteoclast culture studies and murine ovariectomy models, showing reductions in bone resorption markers, but no human pharmacokinetic or efficacy trials have been registered. Overall, evidence strength for most touted benefits beyond phototherapy is preclinical and insufficient to support supplementation claims in humans.

## Nutritional Profile

Xanthotoxin (8-methoxypsoralen, 8-MOP) is a furanocoumarin compound, not a nutritional food source, so traditional macronutrient/micronutrient profiling does not apply. Key bioactive characteristics: • Molecular formula: C₁₂H₈O₄; Molecular weight: 216.19 g/mol • Naturally occurring concentrations: found in Ammi majus (bishop's weed) at approximately 0.5–1.5% dry weight, in Heracleum spp. (hogweed/cow parsnip) at ~0.01–0.1% fresh weight, in celery (Apium graveolens) at trace levels (~1–15 mg/kg in stressed or diseased plants), in parsnip (Pastinaca sativa) at ~2–40 mg/kg (particularly in skin/peel and damaged tissue), in grapefruit at trace amounts (~0.1–1 mg/kg in peel oil), and in parsley (Petroselinum crispum) at ~1–10 mg/kg. • Classification: linear furanocoumarin (psoralen derivative); lipophilic compound with moderate oral bioavailability (~20–50% estimated from pharmacokinetic studies in humans); undergoes extensive first-pass hepatic [metabolism](/ingredients/condition/weight-management) via CYP1A2, CYP2A6, and CYP2E1 cytochrome P450 enzymes. • Peak plasma concentration typically reached within 1–3 hours after oral administration. Half-life approximately 1.5–2.5 hours. Protein binding ~75–90%. • Photoactive compound: absorbs UVA light (320–400 nm) with peak absorption at ~334 nm, enabling its use in PUVA photochemotherapy. • No vitamins, minerals, dietary fiber, or protein content as it is a single phytochemical, not a whole food. • Bioavailability notes: absorption is enhanced when taken with fatty foods due to its lipophilic nature (log P ~1.6); bioavailability varies significantly between individuals due to genetic polymorphisms in CYP enzymes; concurrent consumption of grapefruit juice may alter metabolism through CYP3A4 inhibition. Therapeutic doses in PUVA therapy typically range from 0.4–0.6 mg/kg body weight orally.

## Dosage & Preparation

No clinically studied dosage ranges have been established for xanthotoxin supplements due to insufficient human trial data. Commercial standards are available as neat powder in 10-25 mg vials at ≥98% purity for research purposes only. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Xanthotoxin is a potent photosensitizer; exposure to UVA light after ingestion or topical application significantly increases the risk of severe sunburn, phototoxic reactions, and long-term skin cancer risk, which is why medical PUVA use requires strict UV monitoring. It inhibits cytochrome P450 enzymes, particularly CYP1A2 and CYP3A4, creating clinically relevant interactions with drugs such as warfarin, caffeine, theophylline, and certain antiepileptics, potentially altering their plasma concentrations. Xanthotoxin is contraindicated in individuals with photosensitive conditions (e.g., lupus, porphyria), a history of melanoma, or concurrent use of other photosensitizing agents. It is classified as potentially unsafe during pregnancy due to its DNA-intercalating properties and mutagenic potential under UV activation, and its safety during lactation has not been established.

## Scientific Research

While xanthotoxin is clinically used in PUVA therapy for skin conditions, the research dossier reveals a concerning lack of specific human clinical trials, RCTs, or meta-analyses with available PMIDs. The comprehensive review explicitly notes that clinical study data remain scarce, limiting its therapeutic applications and evidence-based dosing recommendations.

## Historical & Cultural Context

The research dossier provides no information on traditional or historical use of xanthotoxin. Modern pharmacological interest stems solely from its isolation as a bioactive compound from plants like Pepper fruit and Astilbe chinensis rhizomes.

## Synergistic Combinations

Other furocoumarins, vitamin D (for [bone health](/ingredients/condition/bone-health)), [antioxidant](/ingredients/condition/antioxidant)s

## Frequently Asked Questions

### What is xanthotoxin and what plants does it come from?

Xanthotoxin, also known by its pharmaceutical name methoxsalen, is a linear furocoumarin naturally occurring in plants of the Apiaceae family, including Ammi majus (bishop's weed), Angelica archangelica, Petroselinum crispum (parsley), and Ficus carica (fig). It is one of the most studied psoralens and is the active compound in PUVA photochemotherapy used medically for psoriasis and vitiligo.

### Can xanthotoxin help with bone loss or osteoporosis?

Preliminary animal and in vitro studies suggest xanthotoxin can inhibit RANKL-induced osteoclast differentiation by suppressing NFATc1 and c-Fos expression, key transcription factors in bone resorption pathways. Murine ovariectomy models showed measurable reductions in osteoclast activity and bone resorption markers, but no human clinical trials have been conducted, meaning it cannot currently be recommended for osteoporosis prevention or treatment.

### Does xanthotoxin have anticonvulsant effects?

Xanthotoxin demonstrated anticonvulsant activity in rodent seizure models, including pentylenetetrazole-induced and maximal electroshock seizure tests, with proposed mechanisms involving modulation of GABA-A receptor activity and voltage-gated sodium channel inhibition. However, all evidence is preclinical, no human dose-response data exist, and the compound's photosensitizing and CYP-inhibiting properties would complicate its use alongside standard antiepileptic drugs.

### Is xanthotoxin safe to take as a supplement?

Xanthotoxin is not considered safe for unsupervised supplementation due to its potent photosensitizing properties, which dramatically increase phototoxic and skin cancer risk upon UVA exposure, and its inhibition of CYP1A2 and CYP3A4 enzymes, which can cause dangerous drug interactions. Therapeutically, methoxsalen (xanthotoxin) is available only by prescription in many countries and is administered under strict medical supervision with controlled UV dosing.

### What is the difference between xanthotoxin and methoxsalen?

Xanthotoxin and methoxsalen are the same molecule (8-methoxypsoralen, molecular formula C12H8O4); xanthotoxin is the name used in phytochemistry and pharmacognosy when referring to the naturally occurring plant compound, while methoxsalen is the International Nonproprietary Name (INN) used in pharmaceutical and clinical contexts. Both terms describe a linear furocoumarin with identical photosensitizing, anti-inflammatory, and DNA-intercalating properties.

### Does xanthotoxin have photosensitizing properties?

Yes, xanthotoxin is a furocoumarin compound known for photosensitizing effects, meaning it can increase skin sensitivity to UV light when taken orally or applied topically. This property has historically been exploited in PUVA (psoralen + UVA) therapy for skin conditions, though supplemental use carries risk of phototoxic reactions. Individuals taking xanthotoxin supplements should avoid prolonged sun exposure and use high SPF protection to prevent severe burns or skin damage.

### What is the current quality of clinical evidence for xanthotoxin's health benefits?

Most evidence for xanthotoxin's benefits comes from in vitro (test tube) and animal model studies, with very limited human clinical trials available. While preliminary research suggests potential in bone health, seizure management, and anti-inflammatory effects, these findings have not been confirmed in large-scale randomized controlled trials. More rigorous human studies are needed before xanthotoxin can be considered an evidence-based therapeutic for any condition.

### Which populations should avoid xanthotoxin supplementation?

Individuals with photosensitivity disorders, skin cancer history, or those taking phototoxic medications should avoid xanthotoxin due to increased risk of severe photosensitization reactions. Pregnant and breastfeeding women should avoid supplementation due to limited safety data and potential furocoumarin toxicity effects on fetal development. People with liver dysfunction should exercise caution, as xanthotoxin metabolism occurs primarily through hepatic pathways.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*